WOUND CARE MARKET
The wound care market is a very large and a costly component of the United States health care system. Market data estimates that more than 89 million patients are treated annually for all wound conditions at costs in excess of $25 billion. Of these wounds, more than six million are chronic wounds involving various types of skin ulcers that are often difficult and expensive to treat.2 In the US there are approximately 3 million cases of pressure ulcers, 1 million cases of venous stasis ulcers, and 2 million cases of diabetic foot ulcers reported annually.1,2,3
Meeting the Need
Celleration® Inc. is the first to develop a non-contact ultrasound wound treatment system to treat hard to heal wounds, such as pressure ulcers, diabetic ulcers, vascular ulcers and surgical dehiscence. The patented MIST Therapy® technology utilizes ultrasonic sound waves to convey an energized mist of sterile saline to treat these chronic wounds. Wound healing progresses optimally on a wound bed clean of devitalized tissue and controlled bacterial levels. “The MIST Therapy System produces a low energy ultrasound-generated mist used to promote wound healing through wound cleansing and maintenance debridement by the removal of yellow slough, fibrin, tissue exudates and bacteria.”*
* FDA Indication
1 MedTech Insight Feb 2004
2 Advanced Wound Care Biologics: World Market Analysis, Theta Reports,2002
3 Strategic Analysis of Global Wound Care Markets, Frost and Sullivan, 2002
|
